Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Tianlong and KHB Group Showcase Integrated Molecular and Immunoassay Systems

By LabMedica International staff writers
Posted on 17 Nov 2025

Tianlong, together with parent company KHB Group, is presenting its latest systems at MEDICA 2025. More...

The exhibit highlights clinical diagnostics built around the Panall 8000 All‑In‑One Molecular Diagnosis System and the Gentier mini Real‑Time Polymerase Chain Reaction (PCR) System.

Tianlong Panall 800 is an all-in-one molecular diagnosis platform designed for simplicity, security, and full workflow integration. It integrates sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection, and result analysis within a single system. By enabling a true sample-in, result-out process with one-key operation, the Panall 8000 provides significant convenience and efficiency for laboratory professionals.

The Gentier Mini Real Time PCR System is designed for mobile settings, small laboratories, and on-site testing. Its excellent performance and portability address the challenges of limited workspace and fragmented samples in laboratories, making PCR experiments easier, more accurate, and more efficient. The system is suitable for a wide range of applications, including animal disease and infectious disease monitoring, food safety, scientific research, and more.

For immunoassay automation, KHB is highlighting the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer. This compact, fully automated desktop analyzer from the KHB Polaris series is designed for small and medium-sized laboratories, while also supporting emergency testing needs in large hospitals and third-party laboratories.

Related Links:
Tianlong
KHB


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.